What is the address of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE?

The registered office of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE is located at Paddestraat 41, 9620 Zottegem.

Is DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE still active?

Yes. According to the CBE (17 September 2026) DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE is active, legal situation “Normale toestand”, started on 3 November 2017.

Is DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE registered on Peppol?

Yes, DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE is registered on the Peppol network with ID 0208:0683935716.

What is the enterprise number of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE?

The enterprise number of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE is BE0683935716.

Who are the directors of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE?

According to the 2025 annual accounts, the directors of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE are: Diederik Dooremont.

Is DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 November 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE make in 2025?

DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE posted a profit after taxes of € 166,435 in financial year 2025.

What is the revenue of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE?

As a small company, DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 280,525.

DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE (Private Limited)

Q: When was DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE founded?

DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE was founded on 3 November 2017.

Dossier DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE, printed on 17 September 2026 from databakkes.be/en/0683935716/dokter-diederik-dooremont-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE from Zottegem, company number BE0683935716, closed financial year 2025 with a result of € 166,435 after tax. For that financial year DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE recorded a gross margin of € 280,525 and equity of € 20,460. Compared with financial year 2024, the result moved from € 170,718 to € 166,435. The company is profitable. The buffer shrank hard: equity is 87 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.

What it is worth Shrank hard

€ 20,460

▼ 87% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 166,435

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 112,802

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 299,316 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,744

▲ 53% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 140,011

▼ 37% vs 2024

€ 83,788 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,110

▲ 77% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 59,117

▼ 21% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 100,457 Gross margin 2022: € 100,457 First fiscal year in the series	€ 127,529 Gross margin 2023: € 127,529 ▲ 27% vs 2022 (€ 100,457) Favourable step	€ 297,660 Gross margin 2024: € 297,660 ▲ 133% vs 2023 (€ 127,529) Favourable step	€ 280,525 Gross margin 2025: € 280,525 ▼ 6% vs 2024 (€ 297,660) Unfavourable step	▼ 6%
Profit after taxes	€ 30,119 Profit after taxes 2022: € 30,119 First fiscal year in the series	€ 44,722 Profit after taxes 2023: € 44,722 ▲ 48% vs 2022 (€ 30,119) Favourable step	€ 170,718 Profit after taxes 2024: € 170,718 ▲ 282% vs 2023 (€ 44,722) Favourable step	€ 166,435 Profit after taxes 2025: € 166,435 ▼ 3% vs 2024 (€ 170,718) Unfavourable step	▼ 3%
Equity	€ 59,077 Equity 2022: € 59,077 First fiscal year in the series	€ 103,799 Equity 2023: € 103,799 ▲ 76% vs 2022 (€ 59,077) Favourable step	€ 153,341 Equity 2024: € 153,341 ▲ 48% vs 2023 (€ 103,799) Favourable step	€ 20,460 Equity 2025: € 20,460 ▼ 87% vs 2024 (€ 153,341) Unfavourable step	▼ 87%
Total debts	€ 409,028 Total debts 2022: € 409,028 First fiscal year in the series	€ 381,333 Total debts 2023: € 381,333 ▼ 7% vs 2022 (€ 409,028) Favourable step	€ 341,706 Total debts 2024: € 341,706 ▼ 10% vs 2023 (€ 381,333) Favourable step	€ 398,675 Total debts 2025: € 398,675 ▲ 17% vs 2024 (€ 341,706) Unfavourable step	▲ 17%
Cash	€ 28,361 Cash 2022: € 28,361 First fiscal year in the series	€ 71,720 Cash 2023: € 71,720 ▲ 153% vs 2022 (€ 28,361) Favourable step	€ 133,877 Cash 2024: € 133,877 ▲ 87% vs 2023 (€ 71,720) Favourable step	€ 112,802 Cash 2025: € 112,802 ▼ 16% vs 2024 (€ 133,877) Unfavourable step	▼ 16%
Retained profit	€ 40,477 Retained profit 2022: € 40,477 First fiscal year in the series	€ 83,339 Retained profit 2023: € 83,339 ▲ 106% vs 2022 (€ 40,477) Favourable step	€ 132,881 Retained profit 2024: € 132,881 ▲ 59% vs 2023 (€ 83,339) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 132,881) Unfavourable step	▼ 100%
Dividend	€ 70,000 Dividend 2022: € 70,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 70,000) Unchanged	€ 121,176 Dividend 2024: € 121,176 Unchanged (€ 0) Unchanged	€ 299,316 Dividend 2025: € 299,316 ▲ 147% vs 2024 (€ 121,176) Unchanged	▲ 147%
Bank debt	€ 387,483 Bank debt 2022: € 387,483 First fiscal year in the series	€ 305,633 Bank debt 2023: € 305,633 ▼ 21% vs 2022 (€ 387,483) Favourable step	€ 223,148 Bank debt 2024: € 223,148 ▼ 27% vs 2023 (€ 305,633) Favourable step	€ 140,011 Bank debt 2025: € 140,011 ▼ 37% vs 2024 (€ 223,148) Favourable step	▼ 37%
Balance sheet total	€ 468,104 Balance sheet total 2022: € 468,104 First fiscal year in the series	€ 485,132 Balance sheet total 2023: € 485,132 ▲ 4% vs 2022 (€ 468,104) Unchanged	€ 495,047 Balance sheet total 2024: € 495,047 ▲ 2% vs 2023 (€ 485,132) Unchanged	€ 419,135 Balance sheet total 2025: € 419,135 ▼ 15% vs 2024 (€ 495,047) Unchanged	▼ 15%

Key figures of DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE?

What happened at DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 20, 2026 New annual accounts for financial year 2025: profit of € 166,435 (▼ 3% vs 2024). Source: NBB ↗
Nov 3, 2017 New establishment in Zottegem. KBO
2017 Diederik Dooremont became a director. NBB
Nov 3, 2017 Start of the company according to the CBE. KBO

In short

From € 30,119 profit in 2022 to € 166,435 profit in 2025.

Paid € 128,817 in corporate taxes since 2022.

Best year ever: 2024, with € 170,718 profit.

Paid out € 490,492 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE? We notify you, reason included.

Follow DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Diederik Dooremont

DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE

Behind DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE is Diederik Dooremont.

See the full network in the app

Directors

According to the 2025 annual accounts

Diederik Dooremont

Director

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Paddestraat 41

9620 Zottegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0683.935.716
VAT number: BE 0683.935.716
Registered office: Paddestraat 41, 9620 Zottegem
Names & denominations: DOKTER DIEDERIK DOOREMONT, GASTRO-ENTEROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 November 2017
Peppol: Active · Active since 6 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗